

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.20258420 |
| 2 | DNA deamination (GO:0045006) | 8.74570463 |
| 3 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.37132927 |
| 4 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.62917142 |
| 5 | positive regulation of defense response to virus by host (GO:0002230) | 4.58178363 |
| 6 | chaperone-mediated protein transport (GO:0072321) | 4.53017352 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.42273945 |
| 8 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.38370249 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.17564014 |
| 10 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.12707785 |
| 11 | T cell migration (GO:0072678) | 4.08375887 |
| 12 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.00635975 |
| 13 | ATP synthesis coupled proton transport (GO:0015986) | 4.00635975 |
| 14 | protein deneddylation (GO:0000338) | 3.97184504 |
| 15 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.93288896 |
| 16 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.77519277 |
| 17 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.76659144 |
| 18 | negative regulation of ligase activity (GO:0051352) | 3.71912724 |
| 19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.71912724 |
| 20 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.66886660 |
| 21 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.64621349 |
| 22 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.64621349 |
| 23 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.64621349 |
| 24 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.64118254 |
| 25 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.64118254 |
| 26 | negative regulation by host of viral transcription (GO:0043922) | 3.60263741 |
| 27 | DNA demethylation (GO:0080111) | 3.54521550 |
| 28 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.50787006 |
| 29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.48493039 |
| 30 | L-methionine salvage (GO:0071267) | 3.48055275 |
| 31 | L-methionine biosynthetic process (GO:0071265) | 3.48055275 |
| 32 | amino acid salvage (GO:0043102) | 3.48055275 |
| 33 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.45334838 |
| 34 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.44287832 |
| 35 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.44287832 |
| 36 | maturation of 5.8S rRNA (GO:0000460) | 3.41080221 |
| 37 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.39148426 |
| 38 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.38696090 |
| 39 | proteasome assembly (GO:0043248) | 3.38293877 |
| 40 | respiratory electron transport chain (GO:0022904) | 3.36110070 |
| 41 | electron transport chain (GO:0022900) | 3.32812138 |
| 42 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.31979087 |
| 43 | negative regulation of T cell apoptotic process (GO:0070233) | 3.31547238 |
| 44 | DNA dealkylation (GO:0035510) | 3.30428730 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.29017113 |
| 46 | cullin deneddylation (GO:0010388) | 3.28172935 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.26920922 |
| 48 | protein complex biogenesis (GO:0070271) | 3.21265847 |
| 49 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.20929702 |
| 50 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.20929702 |
| 51 | negative regulation of heart rate (GO:0010459) | 3.20183688 |
| 52 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.19292777 |
| 53 | NADH dehydrogenase complex assembly (GO:0010257) | 3.19292777 |
| 54 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.19292777 |
| 55 | kynurenine metabolic process (GO:0070189) | 3.18888085 |
| 56 | rRNA catabolic process (GO:0016075) | 3.17499715 |
| 57 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.15604149 |
| 58 | lymphocyte chemotaxis (GO:0048247) | 3.09736853 |
| 59 | protein-cofactor linkage (GO:0018065) | 3.08936153 |
| 60 | nucleoside diphosphate catabolic process (GO:0009134) | 3.07751215 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.06316166 |
| 62 | behavioral response to nicotine (GO:0035095) | 2.97347219 |
| 63 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.95290731 |
| 64 | response to pheromone (GO:0019236) | 2.94412555 |
| 65 | cytolysis (GO:0019835) | 2.93146581 |
| 66 | positive regulation of cell cycle arrest (GO:0071158) | 2.92535968 |
| 67 | regulation of calcium-mediated signaling (GO:0050848) | 2.91530865 |
| 68 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.89763015 |
| 69 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.88512325 |
| 70 | eosinophil chemotaxis (GO:0048245) | 2.87000860 |
| 71 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.85300536 |
| 72 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.82737974 |
| 73 | negative regulation of viral genome replication (GO:0045071) | 2.82707754 |
| 74 | positive T cell selection (GO:0043368) | 2.81280284 |
| 75 | cellular response to interferon-beta (GO:0035458) | 2.80960718 |
| 76 | regulation of regulatory T cell differentiation (GO:0045589) | 2.79379144 |
| 77 | platelet dense granule organization (GO:0060155) | 2.78365899 |
| 78 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.73898884 |
| 79 | regulation of cellular amine metabolic process (GO:0033238) | 2.73248339 |
| 80 | positive regulation of ligase activity (GO:0051351) | 2.70401338 |
| 81 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.67216973 |
| 82 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.65339832 |
| 83 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.64735087 |
| 84 | pyrimidine nucleoside metabolic process (GO:0006213) | 2.64361481 |
| 85 | tryptophan metabolic process (GO:0006568) | 2.63108845 |
| 86 | response to interferon-beta (GO:0035456) | 2.60652715 |
| 87 | eosinophil migration (GO:0072677) | 2.60316867 |
| 88 | indole-containing compound catabolic process (GO:0042436) | 2.60189661 |
| 89 | indolalkylamine catabolic process (GO:0046218) | 2.60189661 |
| 90 | tryptophan catabolic process (GO:0006569) | 2.60189661 |
| 91 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.60145650 |
| 92 | regulation of cell cycle arrest (GO:0071156) | 2.58927271 |
| 93 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.58807554 |
| 94 | regulation of interleukin-8 secretion (GO:2000482) | 2.57726443 |
| 95 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.56365664 |
| 96 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.55643565 |
| 97 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.55463175 |
| 98 | cytidine metabolic process (GO:0046087) | 10.2152637 |
| 99 | cytidine catabolic process (GO:0006216) | 10.2152637 |
| 100 | cytidine deamination (GO:0009972) | 10.2152637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.65067464 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.01300991 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.87241630 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.81104475 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.56327427 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.24660403 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.05499369 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.03468169 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.68937520 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.63701369 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36518421 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.35622877 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32195774 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.30110044 |
| 15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29273607 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28402309 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.21208704 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.17678912 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.09116957 |
| 20 | TP53_22573176_ChIP-Seq_HFKS_Human | 2.03877992 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.98464524 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.96626069 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87616746 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.80166569 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.79668675 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.78950776 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.76204612 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.67013255 |
| 29 | GATA3_26560356_Chip-Seq_TH2_Human | 1.65956671 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.62609655 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.61013196 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.59614611 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.57048845 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48820737 |
| 35 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.48624026 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48337740 |
| 37 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.46826146 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46749584 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.45658303 |
| 40 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.44124945 |
| 41 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.37163869 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37032332 |
| 43 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.36544888 |
| 44 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.36544888 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34615787 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34129608 |
| 47 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33724102 |
| 48 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.33316533 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32186565 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27054270 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.24982787 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23399851 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22955211 |
| 54 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.22488105 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22470037 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20885417 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20885417 |
| 58 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.19564481 |
| 59 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.18949278 |
| 60 | AR_20517297_ChIP-Seq_VCAP_Human | 1.17751983 |
| 61 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.17531407 |
| 62 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17144242 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17035016 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15034446 |
| 65 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14653458 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13869027 |
| 67 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.12732595 |
| 68 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.12491248 |
| 69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11880321 |
| 70 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10952499 |
| 71 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.10617152 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.09402838 |
| 73 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.09290968 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08885740 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08885740 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07496890 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06874438 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 1.06564161 |
| 79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04374372 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03169329 |
| 81 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.02943735 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00261501 |
| 83 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99906707 |
| 84 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98248873 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97884522 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97682570 |
| 87 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97447266 |
| 88 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.96509244 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95780741 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95450045 |
| 91 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94791793 |
| 92 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94384221 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92319446 |
| 94 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91978383 |
| 95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91268718 |
| 96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90926729 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90622670 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90355459 |
| 99 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90339611 |
| 100 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89481312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.11328063 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 2.91681467 |
| 3 | MP0001986_abnormal_taste_sensitivity | 2.88403422 |
| 4 | MP0009785_altered_susceptibility_to | 2.62375265 |
| 5 | MP0008877_abnormal_DNA_methylation | 2.49565878 |
| 6 | MP0002102_abnormal_ear_morphology | 2.44892263 |
| 7 | MP0002163_abnormal_gland_morphology | 2.44178542 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.42216600 |
| 9 | MP0002006_tumorigenesis | 2.26568420 |
| 10 | MP0006292_abnormal_olfactory_placode | 2.22017825 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.15959865 |
| 12 | MP0001984_abnormal_olfaction | 2.05195569 |
| 13 | MP0003787_abnormal_imprinting | 2.04583245 |
| 14 | MP0003045_fibrosis | 2.00163765 |
| 15 | MP0002166_altered_tumor_susceptibility | 1.92400753 |
| 16 | MP0006082_CNS_inflammation | 1.90226357 |
| 17 | MP0000372_irregular_coat_pigmentation | 1.81870793 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 1.79977242 |
| 19 | MP0003878_abnormal_ear_physiology | 1.79977242 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.72266857 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 1.68601497 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.67609949 |
| 23 | MP0001529_abnormal_vocalization | 1.65252330 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.63142238 |
| 25 | MP0001485_abnormal_pinna_reflex | 1.61393496 |
| 26 | MP0009764_decreased_sensitivity_to | 1.51949370 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.50633968 |
| 28 | MP0006072_abnormal_retinal_apoptosis | 1.49614076 |
| 29 | MP0003448_altered_tumor_morphology | 1.49000320 |
| 30 | MP0001800_abnormal_humoral_immune | 1.44799282 |
| 31 | MP0005025_abnormal_response_to | 1.41785801 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.40546653 |
| 33 | MP0002723_abnormal_immune_serum | 1.40510894 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.39908434 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.39693913 |
| 36 | MP0005253_abnormal_eye_physiology | 1.39104576 |
| 37 | MP0001905_abnormal_dopamine_level | 1.37117924 |
| 38 | MP0003195_calcinosis | 1.34918455 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.34765331 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.32466406 |
| 41 | MP0001819_abnormal_immune_cell | 1.29777315 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.28804073 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.28059577 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.27012288 |
| 45 | MP0003567_abnormal_fetal_cardiomyocyte | 1.26888760 |
| 46 | MP0001853_heart_inflammation | 1.24439687 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.22683041 |
| 48 | MP0005248_abnormal_Harderian_gland | 1.21365872 |
| 49 | MP0004885_abnormal_endolymph | 1.20260470 |
| 50 | MP0004924_abnormal_behavior | 1.19255033 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.19255033 |
| 52 | MP0009745_abnormal_behavioral_response | 1.18814736 |
| 53 | MP0001486_abnormal_startle_reflex | 1.15970609 |
| 54 | MP0003866_abnormal_defecation | 1.14879004 |
| 55 | MP0001790_abnormal_immune_system | 1.14387199 |
| 56 | MP0005387_immune_system_phenotype | 1.14387199 |
| 57 | MP0003718_maternal_effect | 1.12428268 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.10808011 |
| 59 | MP0003786_premature_aging | 1.10700268 |
| 60 | MP0000647_abnormal_sebaceous_gland | 1.08650690 |
| 61 | MP0002090_abnormal_vision | 1.07487552 |
| 62 | MP0005165_increased_susceptibility_to | 1.06651887 |
| 63 | MP0003879_abnormal_hair_cell | 1.04648842 |
| 64 | MP0002272_abnormal_nervous_system | 1.03282159 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.03117760 |
| 66 | MP0001346_abnormal_lacrimal_gland | 1.00444298 |
| 67 | MP0001970_abnormal_pain_threshold | 0.97177928 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 0.96955532 |
| 69 | MP0001188_hyperpigmentation | 0.96775299 |
| 70 | MP0008873_increased_physiological_sensi | 0.96544723 |
| 71 | MP0004484_altered_response_of | 0.95982528 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.95825211 |
| 73 | MP0001968_abnormal_touch/_nociception | 0.95460868 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.95085930 |
| 75 | MP0001542_abnormal_bone_strength | 0.93723704 |
| 76 | MP0009046_muscle_twitch | 0.93513837 |
| 77 | MP0005423_abnormal_somatic_nervous | 0.93363485 |
| 78 | MP0000716_abnormal_immune_system | 0.92219332 |
| 79 | MP0002733_abnormal_thermal_nociception | 0.91876017 |
| 80 | MP0008872_abnormal_physiological_respon | 0.90005915 |
| 81 | MP0002736_abnormal_nociception_after | 0.89377721 |
| 82 | MP0008007_abnormal_cellular_replicative | 0.89069898 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.88042460 |
| 84 | MP0002398_abnormal_bone_marrow | 0.87410518 |
| 85 | MP0001919_abnormal_reproductive_system | 0.86690859 |
| 86 | MP0005389_reproductive_system_phenotype | 0.85609685 |
| 87 | MP0003436_decreased_susceptibility_to | 0.81848921 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.79587915 |
| 89 | MP0009763_increased_sensitivity_to | 0.79233391 |
| 90 | MP0004142_abnormal_muscle_tone | 0.77784312 |
| 91 | MP0001764_abnormal_homeostasis | 0.77531654 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.77271517 |
| 93 | MP0000689_abnormal_spleen_morphology | 0.77097031 |
| 94 | MP0002419_abnormal_innate_immunity | 0.76604238 |
| 95 | MP0001440_abnormal_grooming_behavior | 0.75824059 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.75670007 |
| 97 | MP0001845_abnormal_inflammatory_respons | 0.75448981 |
| 98 | MP0005332_abnormal_amino_acid | 0.75199864 |
| 99 | MP0003011_delayed_dark_adaptation | 0.74647895 |
| 100 | MP0000858_altered_metastatic_potential | 0.74188803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 7.14791888 |
| 2 | T lymphocytopenia (HP:0005403) | 4.42331518 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.11625115 |
| 4 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.07043270 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.07043270 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.00254179 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.84880215 |
| 8 | Severe combined immunodeficiency (HP:0004430) | 3.75746565 |
| 9 | Hepatic necrosis (HP:0002605) | 3.70196701 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.66770973 |
| 11 | IgG deficiency (HP:0004315) | 3.61091839 |
| 12 | Renal cortical cysts (HP:0000803) | 3.59824928 |
| 13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.59216774 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.51941974 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.50107219 |
| 16 | Combined immunodeficiency (HP:0005387) | 3.29376453 |
| 17 | Adrenal hypoplasia (HP:0000835) | 3.25635045 |
| 18 | Pancreatic cysts (HP:0001737) | 3.23167832 |
| 19 | Decreased central vision (HP:0007663) | 3.18972346 |
| 20 | Increased IgM level (HP:0003496) | 3.13336901 |
| 21 | Increased CSF lactate (HP:0002490) | 3.12490642 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.02812599 |
| 23 | Progressive macrocephaly (HP:0004481) | 2.96133514 |
| 24 | Acute encephalopathy (HP:0006846) | 2.93647668 |
| 25 | Abnormality of T cells (HP:0002843) | 2.89235994 |
| 26 | Thyroiditis (HP:0100646) | 2.85035515 |
| 27 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.84281855 |
| 28 | Abnormality of eosinophils (HP:0001879) | 2.83868089 |
| 29 | Abnormality of midbrain morphology (HP:0002418) | 2.83585186 |
| 30 | Molar tooth sign on MRI (HP:0002419) | 2.83585186 |
| 31 | Cerebral edema (HP:0002181) | 2.62930069 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.59368127 |
| 33 | Type 2 muscle fiber atrophy (HP:0003554) | 2.54566108 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.51480351 |
| 35 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.49651796 |
| 36 | Septo-optic dysplasia (HP:0100842) | 2.45282078 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 2.45007666 |
| 38 | Absent septum pellucidum (HP:0001331) | 2.39361816 |
| 39 | Cerebral hypomyelination (HP:0006808) | 2.38605723 |
| 40 | Muscle fiber atrophy (HP:0100295) | 2.36677227 |
| 41 | Optic disc pallor (HP:0000543) | 2.36516019 |
| 42 | True hermaphroditism (HP:0010459) | 2.35970895 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 2.35968192 |
| 44 | Congenital, generalized hypertrichosis (HP:0004540) | 2.34064301 |
| 45 | Methylmalonic aciduria (HP:0012120) | 2.33808381 |
| 46 | Eosinophilia (HP:0001880) | 2.32552364 |
| 47 | Type I transferrin isoform profile (HP:0003642) | 2.30184464 |
| 48 | Congenital stationary night blindness (HP:0007642) | 2.29434601 |
| 49 | Hypoproteinemia (HP:0003075) | 2.28081350 |
| 50 | Nephronophthisis (HP:0000090) | 2.27247967 |
| 51 | Methylmalonic acidemia (HP:0002912) | 2.26935320 |
| 52 | Pancreatic fibrosis (HP:0100732) | 2.25327328 |
| 53 | Increased serum lactate (HP:0002151) | 2.23127820 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.21649922 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.20712336 |
| 56 | Chronic sinusitis (HP:0011109) | 2.18737671 |
| 57 | Pancytopenia (HP:0001876) | 2.13628893 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.12187187 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.12187187 |
| 60 | Bronchitis (HP:0012387) | 2.11531456 |
| 61 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.10015517 |
| 62 | B lymphocytopenia (HP:0010976) | 2.08658852 |
| 63 | Respiratory failure (HP:0002878) | 2.06866847 |
| 64 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.06653808 |
| 65 | CNS demyelination (HP:0007305) | 2.06030209 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.01144734 |
| 67 | Sclerocornea (HP:0000647) | 2.00655812 |
| 68 | Lactic acidosis (HP:0003128) | 1.98232320 |
| 69 | Abnormality of the alveolar ridges (HP:0006477) | 1.97683257 |
| 70 | Abnormality of the pons (HP:0007361) | 1.94569776 |
| 71 | Hypoplasia of the uterus (HP:0000013) | 1.92656132 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 1.90886029 |
| 73 | Neuroendocrine neoplasm (HP:0100634) | 1.88399765 |
| 74 | Encephalitis (HP:0002383) | 1.87972304 |
| 75 | Abnormality of the septum pellucidum (HP:0007375) | 1.86701617 |
| 76 | Leukocytosis (HP:0001974) | 1.86192829 |
| 77 | Submucous cleft hard palate (HP:0000176) | 1.85991450 |
| 78 | Constricted visual fields (HP:0001133) | 1.85967565 |
| 79 | Increased muscle lipid content (HP:0009058) | 1.85451900 |
| 80 | Reduced antithrombin III activity (HP:0001976) | 1.85280463 |
| 81 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.85046225 |
| 82 | Emotional lability (HP:0000712) | 1.84957118 |
| 83 | Type II lissencephaly (HP:0007260) | 1.84245964 |
| 84 | Parakeratosis (HP:0001036) | 1.83562913 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79793508 |
| 86 | Lethargy (HP:0001254) | 1.77266041 |
| 87 | Abnormality of the prostate (HP:0008775) | 1.76259048 |
| 88 | Abnormality of the renal medulla (HP:0100957) | 1.73585321 |
| 89 | Recurrent corneal erosions (HP:0000495) | 1.73384536 |
| 90 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.72318076 |
| 91 | Abnormal albumin level (HP:0012116) | 1.72307834 |
| 92 | Hypoalbuminemia (HP:0003073) | 1.72307834 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.71958718 |
| 94 | Sparse eyelashes (HP:0000653) | 1.71126813 |
| 95 | Conical tooth (HP:0000698) | 1.70618885 |
| 96 | Lymphoma (HP:0002665) | 1.70312895 |
| 97 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.66981777 |
| 98 | Palpitations (HP:0001962) | 1.66060009 |
| 99 | Nonprogressive disorder (HP:0003680) | 1.65715840 |
| 100 | Neonatal respiratory distress (HP:0002643) | 1.65382667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.74843307 |
| 2 | TXK | 3.73907070 |
| 3 | EIF2AK3 | 3.36997099 |
| 4 | STK16 | 3.31789519 |
| 5 | BUB1 | 3.17567285 |
| 6 | KDR | 2.95653537 |
| 7 | ZAK | 2.82130339 |
| 8 | TAOK1 | 2.76827649 |
| 9 | SCYL2 | 2.68501410 |
| 10 | MAP4K2 | 2.66198291 |
| 11 | ADRBK2 | 2.64245282 |
| 12 | BMPR2 | 2.43746565 |
| 13 | EIF2AK1 | 2.19724364 |
| 14 | TESK2 | 2.19315328 |
| 15 | SRPK1 | 2.15660785 |
| 16 | MST4 | 2.07653973 |
| 17 | LIMK1 | 2.02544221 |
| 18 | TLK1 | 1.82369357 |
| 19 | VRK2 | 1.81330201 |
| 20 | CDK19 | 1.71850988 |
| 21 | TSSK6 | 1.71499742 |
| 22 | NUAK1 | 1.60164916 |
| 23 | VRK1 | 1.57102777 |
| 24 | WNK3 | 1.55055171 |
| 25 | ITK | 1.44380827 |
| 26 | PRKD3 | 1.36664276 |
| 27 | NME1 | 1.36375829 |
| 28 | TRIM28 | 1.34896418 |
| 29 | KIT | 1.25084498 |
| 30 | MAP2K7 | 1.16327071 |
| 31 | AKT3 | 1.13550578 |
| 32 | GRK1 | 1.13362633 |
| 33 | FRK | 1.09421685 |
| 34 | BCKDK | 1.06694305 |
| 35 | PDK2 | 0.97484119 |
| 36 | RIPK4 | 0.94240441 |
| 37 | PINK1 | 0.93874587 |
| 38 | PIM2 | 0.93847748 |
| 39 | BMPR1B | 0.81148499 |
| 40 | EIF2AK2 | 0.80823921 |
| 41 | SYK | 0.79359773 |
| 42 | IKBKB | 0.78544521 |
| 43 | PLK3 | 0.77128648 |
| 44 | TESK1 | 0.74971408 |
| 45 | TIE1 | 0.72720262 |
| 46 | PHKG2 | 0.72656897 |
| 47 | PHKG1 | 0.72656897 |
| 48 | PLK1 | 0.68031189 |
| 49 | PRKCQ | 0.63910361 |
| 50 | NEK6 | 0.63384623 |
| 51 | LCK | 0.62636561 |
| 52 | CAMKK2 | 0.62401905 |
| 53 | ROCK1 | 0.62027017 |
| 54 | CSNK1G3 | 0.60023722 |
| 55 | RPS6KA5 | 0.59883344 |
| 56 | MAPK13 | 0.58353823 |
| 57 | PIK3CG | 0.57494725 |
| 58 | TYRO3 | 0.56467872 |
| 59 | DYRK2 | 0.56368136 |
| 60 | CAMK2A | 0.55872017 |
| 61 | GRK7 | 0.55391380 |
| 62 | CSNK1A1L | 0.52495798 |
| 63 | TAF1 | 0.52276776 |
| 64 | RPS6KA4 | 0.49447501 |
| 65 | MAP3K4 | 0.46424991 |
| 66 | DYRK1B | 0.46083431 |
| 67 | PIM1 | 0.43172316 |
| 68 | PAK1 | 0.41970937 |
| 69 | NEK1 | 0.41841197 |
| 70 | INSRR | 0.41604554 |
| 71 | FES | 0.41567629 |
| 72 | OBSCN | 0.40367117 |
| 73 | PRKCA | 0.39847642 |
| 74 | MKNK2 | 0.39673570 |
| 75 | CSNK1A1 | 0.39088851 |
| 76 | PRKACA | 0.38547240 |
| 77 | MAP4K1 | 0.38217438 |
| 78 | TEC | 0.37517713 |
| 79 | CDC7 | 0.37308988 |
| 80 | ADRBK1 | 0.36887512 |
| 81 | AURKB | 0.36745112 |
| 82 | MAP3K14 | 0.36350966 |
| 83 | ILK | 0.35834926 |
| 84 | MARK1 | 0.35414760 |
| 85 | IKBKE | 0.35261316 |
| 86 | FYN | 0.34788547 |
| 87 | CSNK1G1 | 0.34070704 |
| 88 | MYLK | 0.33006335 |
| 89 | CHUK | 0.32755686 |
| 90 | ACVR1B | 0.31043083 |
| 91 | DAPK1 | 0.30932729 |
| 92 | PRKCD | 0.30680757 |
| 93 | BTK | 0.30325706 |
| 94 | BRSK2 | 0.29737756 |
| 95 | CSNK1G2 | 0.29486339 |
| 96 | ATR | 0.27575555 |
| 97 | IRAK3 | 0.27531416 |
| 98 | FGFR1 | 0.27202727 |
| 99 | LYN | 0.27018979 |
| 100 | CDK6 | 0.26285941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.75186161 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.76164026 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.59068307 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.23559067 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.40915363 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.28184848 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.14649764 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.10909266 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.06865340 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 1.97768230 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93168515 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.88920467 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87431815 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84362432 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.78911692 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77607163 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.72211332 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.72009175 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.67863629 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.66216637 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.60005704 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.39593212 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32458388 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.32054939 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28137134 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24512713 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19905113 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19811686 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15040169 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14771859 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.13000256 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.11942199 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.10646502 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.10366555 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09466311 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.09463183 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08883040 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07231149 |
| 39 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05106844 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01192159 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 0.98067009 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 0.97592234 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 0.89143269 |
| 44 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88244743 |
| 45 | Asthma_Homo sapiens_hsa05310 | 0.87624571 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86638105 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81481979 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80669420 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80231653 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71102402 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70170912 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.70012726 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69458706 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69331475 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68226608 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 0.67919713 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67860319 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66836009 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65574542 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65152036 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64884490 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.63978304 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62974486 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61881547 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61488067 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60649400 |
| 67 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59891910 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57226586 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56616780 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55526873 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55065511 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54530844 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53643118 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.53430282 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53031709 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52726616 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52369869 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51638649 |
| 79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50739728 |
| 80 | Taste transduction_Homo sapiens_hsa04742 | 0.50376400 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.48992656 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48749360 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46798375 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46118399 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45417868 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44833989 |
| 87 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.43604076 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42831492 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42300548 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.39266593 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38423067 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38147284 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36717988 |
| 94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35339792 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.33893889 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32383298 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29599417 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28855760 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26543661 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.25734006 |

